Growth Metrics

bioAffinity Technologies (BIAF) Current Leases (2023 - 2025)

Historic Current Leases for bioAffinity Technologies (BIAF) over the last 3 years, with Q3 2025 value amounting to $136197.0.

  • bioAffinity Technologies' Current Leases fell 6487.78% to $136197.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $136197.0, marking a year-over-year decrease of 6487.78%. This contributed to the annual value of $395301.0 for FY2024, which is 816.44% up from last year.
  • Per bioAffinity Technologies' latest filing, its Current Leases stood at $136197.0 for Q3 2025, which was down 6487.78% from $179844.0 recorded in Q2 2025.
  • In the past 5 years, bioAffinity Technologies' Current Leases registered a high of $403584.0 during Q1 2025, and its lowest value of $136197.0 during Q3 2025.
  • For the 3-year period, bioAffinity Technologies' Current Leases averaged around $331055.2, with its median value being $372787.0 (2024).
  • Data for bioAffinity Technologies' Current Leases shows a peak YoY increase of 826.13% (in 2025) and a maximum YoY decrease of 6487.78% (in 2025) over the last 5 years.
  • Over the past 3 years, bioAffinity Technologies' Current Leases (Quarter) stood at $365463.0 in 2023, then increased by 8.16% to $395301.0 in 2024, then plummeted by 65.55% to $136197.0 in 2025.
  • Its Current Leases stands at $136197.0 for Q3 2025, versus $179844.0 for Q2 2025 and $403584.0 for Q1 2025.